Search results for “Pancreas adenocarcinoma” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 49 patents, we discovered top 17 key players by total patent application. BioLineRx Ltd., Merck Sharp & Dohme Corp., Shanghai Laiyi Biopharmaceutical Research & Development Center are dominant in this area. They take 46.94% of the total patent filing.
BioLineRx Ltd.
Israel
Patent: 10
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 7
Shanghai Laiyi Biopharmaceutical Research & Development Center
Shanghai Shi, China
Patent: 6
Immunovia AB
Sweden
Patent: 5
Ipsen Biopharm Ltd.
WALES, United Kingdom
Patent: 5
Prestige BioPharma Pte. Ltd.
Singapore
Patent: 4
Biokine Therapeutics Ltd.
Israel
Patent: 3
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 2
Natimab Therapeutics Srl
TURIN, Italy
Patent: 2
Cancer Research Ventures Ltd.
United Kingdom
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 27 patents applied in the last 5 years. We discover 17 most active companies in this area. The fast-growing BioLineRx Ltd., Merck Sharp & Dohme Corp., Cellbitec SL take 74.07% of patent filing during this period.
BioLineRx Ltd.
Israel
Patent: 10
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 7
Cellbitec SL
ANDALUSIA, Spain
Patent: 3
Biokine Therapeutics Ltd.
Israel
Patent: 3
Universita' Degli Studi di Roma La Sapienza
Italy
Patent: 2
Università Campus Bio-Medico di Roma
Lazio, Italy
Patent: 2
Ipsen Biopharm Ltd.
WALES, United Kingdom
Patent: 1
Peking Union Medical College Hospital
Beijing Shi, China
Patent: 1
Zhenhe (Beijing) Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
Immunovia AB
Sweden
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 27 patents in last 5 years, we discover 14 new entrants. BioLineRx Ltd., Merck Sharp & Dohme Corp., Cellbitec SL are the most active new entrants in this area.
BioLineRx Ltd.
Israel
Patent: 10
Merck Sharp & Dohme Corp.
New Jersey, United States
Patent: 7
Cellbitec SL
ANDALUSIA, Spain
Patent: 3
Biokine Therapeutics Ltd.
Israel
Patent: 3
Universita' Degli Studi di Roma La Sapienza
Italy
Patent: 2
Università Campus Bio-Medico di Roma
Lazio, Italy
Patent: 2
Peking Union Medical College Hospital
Beijing Shi, China
Patent: 1
Zhenhe (Beijing) Technology Co., Ltd.
Jiangsu Sheng, China
Patent: 1
University of Florida
United States
Patent: 1
New York University
New York, United States
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 27 patents, we discovered top 9 universities and scientific research institutions by total patent application. The Johns Hopkins University, Shanghai Jiao Tong University, University of Nebraska are dominant in this area. They take 37.04% of the total patent filing.
The Johns Hopkins University
United States
Patent: 3
Shanghai Jiao Tong University
Shanghai Shi, China
Patent: 3
University of Nebraska
Nebraska, United States
Patent: 2
Università Campus Bio-Medico di Roma
Lazio, Italy
Patent: 2
National University of Singapore
Central Region, Singapore
Patent: 1
New York University
New York, United States
Patent: 1
The Scripps Research Institute
California, United States
Patent: 1
Agency for Science, Technology & Research
Central Region, Singapore
Patent: 1
Institute Of Cancer Research
United Kingdom
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: